Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05757037

Laser Acupuncture on Irritable Bowel Syndrome in Females

Constipation-predominant Irritable Bowel Syndrome Clinical Trial

Official title:
Laser Acupuncture for Treatment of Female Patients With Irritable Bowel Syndrome:RCT

Clinical Trial Summary

The aim of the study to investigate effect of laser acupuncture on constipation predominant irritable bowel syndrome in female patients

Clinical Trial Description

Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder characterized by recurrent abdominal pain and/or bloating related to defecation without reliable biological markers . IBS is associated with substantial burden, such as higher levels of anxiety, lost productivity at work, work absenteeism (Pimentel, 2018). IBS has a strong predominance in women IBS-C includes a wide range of symptoms, and its pathophysiology is complex and not fully understood. Visceral hypersensitivity and delayed gut transit are recognized as major pathophysiological mechanisms in IBS-C. Visceral hypersensitivity may account for symptoms of abdominal pain, bloating, and discomfort. Delayed gut transit causes constipation The unsatisfactory treatment responses and adverse effects associated with pharmacologic therapies have resulted in a higher demand for alternative therapies Acupoints and manipulations are the same in both the experimental and the control groups. The participants in the control group will receive sham laser acupuncture treatment, without any laser output, while the participants in the experimental group will sequentially receive 0.375J of energy at each of the following acupoints: Baihui (GV20), Yintang (GV29), Taichong (LR3), Zusanli (ST36), Sanyinjiao (SP6), Tianshu (ST25), and Shangjuxu (ST37) acupoint .Using a gallium aluminum arsenide LaserPen (maximal power, 150 mW; wavelength, 810 nm; area of probe, 0.03 cm2; power density, 5W/cm2; pulsed wave; and Bahr frequencies [B1: 599.5Hz, B2: 1199Hz, B3: 2398Hz, B4: 4776Hz, B5: 9552 Hz, B6: 19,104Hz, and B7: 38,208Hz]. The laser treatment will be applied to each point for 5 seconds, to deliver a total treatment dose of 4.5J/cm2 . intervention will be 3t/ week for 6 weeks in both groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05757037
Study type Interventional
Source Cairo University
Contact sara Magdy Ahmed, lecturer
Phone 01063998331
Email saramagdy87@cu.edu.eg
Status Recruiting
Phase N/A
Start date March 1, 2023
Completion date September 1, 2024
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00742872 - Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome Phase 3
Completed NCT05164861 - Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations N/A
Withdrawn NCT05321953 - The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation N/A
Not yet recruiting NCT06319729 - A Chinese Herbal Medicine for IBS-C Phase 2
Completed NCT01085643 - Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) N/A
Completed NCT03150212 - Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype N/A
Completed NCT05392439 - Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome N/A
Not yet recruiting NCT05921383 - Anorectal Manometry of Patients With Constipation Predominant IBS
Recruiting NCT05134584 - Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Phase 4
Terminated NCT03336034 - Assessment of Responsiveness to Treatment by Experience Sampling Method
Not yet recruiting NCT04666155 - MOWOOT Device Treatment for Adults With Chronic Constipation N/A
Not yet recruiting NCT05941650 - To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome N/A
Completed NCT00945334 - Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome N/A
Completed NCT00912301 - Cheno Effect on Transit in Health and IBS-C Phase 2
Terminated NCT00607971 - Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) Phase 3